ClinicalTrials.Veeva

Menu

Implicit and Explicit Assessment of Suicide Risk (MIERIS)

C

Centre Hospitalier Universitaire, Amiens

Status

Enrolling

Conditions

Suicide Risk Factor
Prevention, Suicide
Suicide
Implicit Association Test

Treatments

Other: Implicit Attitude Test

Study type

Interventional

Funder types

Other

Identifiers

NCT05903469
PI2020_843_0118

Details and patient eligibility

About

In 2007 Nock & Banaji developed a so-called implicit suicide risk measurement using a computer tool: the Implicit Association Test (IAT). This measurement, associated with traditional evaluations, makes it possible to better predict suicidal recurrence. In 2020, the Poitiers team of Tello was able to replicate these results on a French population. However, although a high IAT score predicts the onset of suicide at 1 year, there is no data on how this score changes over time nor even data concerning the measure's ability to differentiate a population with explicit suicidal ideation from a population without explicit suicidal ideation. The investigators therefore seek to demonstrate an evolution of implicit suicidal ideation over time by replicating the measurement at inclusion, at 6 months and at 12 months, for different patient profiles: Suicidal ideation vs No suicidal ideation and suicide attempt vs no suicide attempt. Patients will be recruited from the emergency-unit of CHU Amiens-Picardie and will take the suicide-IAT as well as various questionnaires.

Enrollment

108 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Person presenting to emergencies for psychiatric reasons
  • Adult person
  • Free and informed consent signed
  • Person speaking and writing French fluently

Exclusion criteria

  • Neurological disorders or major cognitive deterioration: presence of confusion
  • Acute psychotic decompensation
  • Troubled acute behavior
  • Abuse Impregnation of a toxic substance and / or drug impairing cognitive functions at the time of assessment
  • Adult under protective measure.

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

108 participants in 3 patient groups

Patient with explicit suicidal ideation and suicide attempt
Experimental group
Treatment:
Other: Implicit Attitude Test
Patient with explicit suicidal ideation without suicide attempt
Experimental group
Treatment:
Other: Implicit Attitude Test
Patient without explicit suicidal ideation
Active Comparator group
Treatment:
Other: Implicit Attitude Test

Trial contacts and locations

1

Loading...

Central trial contact

Jérôme Thilliez, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems